| Schedule of Segment Reporting Information, by Segment |
The following table is a comparative summary of the Company’s net sales and segment profit by reportable segment for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
| |
2023 |
2022 (*) |
|
2023 |
|
2022 (*) |
Segment Net Sales:
|
|
|
|
|
|
|
|
| Cannabinoid |
$ |
1,873
|
|
|
$ |
745 |
|
|
$ |
3,095
|
|
|
$ |
2,553 |
|
| Non-Cannabinoid |
3,108
|
|
|
3,355 |
|
|
5,864
|
|
|
6,588 |
|
| Total net sales |
4,981
|
|
|
4,100 |
|
|
8,959
|
|
|
9,141 |
|
| |
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
| Cannabinoid |
(1,697) |
|
|
(2,706) |
|
|
(4,012) |
|
|
(8,412) |
|
| Non-Cannabinoid |
831
|
|
|
666 |
|
|
1,278
|
|
|
1,014 |
|
| Total segment loss |
$ |
(866) |
|
|
$ |
(2,040) |
|
|
$ |
(2,734) |
|
|
$ |
(7,398) |
|
| |
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
| Total segment loss |
(866) |
|
|
(2,040) |
|
|
(2,734) |
|
|
(7,398) |
|
| Unallocated corporate expenses |
(2,571) |
|
|
(1,843) |
|
|
(4,129) |
|
|
(5,376) |
|
| Non-cash share-based compensation |
(434) |
|
|
(1,148) |
|
|
(902) |
|
|
(1,648) |
|
| Depreciation and amortization |
696
|
|
|
(317) |
|
|
460
|
|
|
(644) |
|
|
|
|
|
|
|
|
|
| Loss from continuing operations before income taxes |
$ |
(3,175) |
|
|
$ |
(5,348) |
|
|
$ |
(7,305) |
|
|
$ |
(15,066) |
|
| |
|
|
|
|
|
|
|
| Loss on debt extinguishment, net |
—
|
|
|
— |
|
|
—
|
|
|
2,263 |
|
|
|
|
|
|
|
|
|
| Loss (Gain) on remeasurement of warrant liability |
11
|
|
|
(1,323) |
|
|
55
|
|
|
(1,813) |
|
| Gain on investment |
—
|
|
|
(6,851) |
|
|
—
|
|
|
(6,851) |
|
| Foreign exchange loss |
67
|
|
|
264 |
|
|
22
|
|
|
475 |
|
| Interest and amortization of debt issuance cost |
35
|
|
|
645 |
|
|
18
|
|
|
2,754 |
|
| Other (income) expense, net |
(27) |
|
|
61 |
|
|
12
|
|
|
9 |
|
| Income (loss) before loss from equity investment |
$ |
(3,261) |
|
|
$ |
1,856 |
|
|
$ |
(7,412) |
|
|
$ |
(11,903) |
|
(*)Prior period numbers are re-stated to exclude discontinued operations to make it comparative with current period numbers.
|
| Schedule of Disaggregation of Revenue |
The following table disaggregates the Company’s revenue by channel for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
| Mass retail |
$ |
2,991
|
|
|
$ |
1,683 |
|
|
$ |
5,515
|
|
|
$ |
4,496 |
|
| Distributors |
1,552
|
|
|
1,664 |
|
|
2,815
|
|
|
3,322 |
|
| Specialty, health and other retail |
94
|
|
|
560 |
|
|
254
|
|
|
952 |
|
| E-commerce |
344
|
|
|
193 |
|
|
375
|
|
|
371 |
|
| Total |
$ |
4,981
|
|
|
$ |
4,100 |
|
|
$ |
8,959
|
|
|
$ |
9,141 |
|
The following table represents the Company's revenues attributed to countries based on location of customer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
Six Months Ended June 30, |
|
2023 |
2022 |
2023 |
|
2022 |
| United States |
$ |
3,108
|
|
|
$ |
3,275 |
|
$ |
5,864
|
|
|
$ |
6,508 |
|
| Israel |
350
|
|
|
$ |
69 |
|
$ |
600
|
|
|
$ |
707 |
|
| Australia |
671
|
|
|
— |
|
707
|
|
|
368 |
|
| Brazil |
384
|
|
|
277 |
|
1,271
|
|
|
920 |
|
| Germany |
—
|
|
|
300 |
|
9
|
|
|
445 |
|
| Other |
468
|
|
|
179 |
|
508
|
|
|
193 |
|
| Total |
$ |
4,981
|
|
|
$ |
4,100 |
|
$ |
8,959
|
|
|
$ |
9,141 |
|
|
| Schedule of Revenue by Major Customers by Reporting Segments |
Customers with an accounts receivable balance of 10% or greater of total accounts receivable and customers with net revenue of 10% or greater of total revenues are presented below for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of Revenues |
|
Percentage of Accounts Receivable |
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
June 30, |
|
December 31, |
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
Customer A (a)
|
|
11% |
|
10% |
|
13% |
|
10% |
|
* |
|
18% |
Customer B (b)
|
|
* |
|
* |
|
* |
|
* |
|
14% |
|
13% |
Customer C (b)
|
|
* |
|
* |
|
12% |
|
* |
|
* |
|
* |
Customer D (b)
|
|
* |
|
* |
|
* |
|
* |
|
* |
|
15% |
Customer E (b)
|
|
* |
|
* |
|
* |
|
* |
|
* |
|
10% |
Customer F (b)
|
|
* |
|
* |
|
* |
|
* |
|
10% |
|
* |
* denotes less than 10%
(a) net sales attributed are reflected in the non-cannabinoid segments
(b) net sales attributed are reflected in the cannabinoid segments
|
| Schedule of Long-lived Assets by Geographic Areas |
The following table disaggregates the Company’s long-lived assets, by segment for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
2023 |
|
December 31,
2022 |
Long-lived assets
|
|
|
|
| Cannabinoid |
$ |
12,978
|
|
|
$ |
15,308 |
|
| Non-Cannabinoid |
116
|
|
|
155 |
|
| Total |
$ |
13,094
|
|
|
$ |
15,463 |
|
|